We are live on ! Find out more
ACH

ArrowMark Colorado Holdings Portfolio holdings

AUM $3.76B
1-Year Est. Return 21.77%
This Fund
S&P 500
This Quarter Est. Return
-0.05%
1 Year Est. Return
+21.77%
3 Year Est. Return
+58.74%
5 Year Est. Return
+55.15%
10 Year Est. Return
+679.66%
AUM
$12.8B
AUM Growth
-$503M
Cap. Flow
-$241M
Cap. Flow %
-1.88%
Top 10 Hldgs %
22.58%
Holding
382
New
39
Increased
93
Reduced
133
Closed
24

Sector Composition

Rank Sector Weight
1 Healthcare 26.28%
2 Industrials 21.22%
3 Technology 18.95%
4 Consumer Discretionary 13.7%
5 Communication Services 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNDT
376
DELISTED
Mandiant, Inc. Common Stock
MNDT
-2,897,120
Closed -$58.6M
WBT
377
DELISTED
Welbilt, Inc.
WBT
-460,000
Closed -$10.6M
YSAC.U
378
DELISTED
Yellowstone Acquisition Company Units, each consisting of one share of Class A common stock and one-
YSAC.U
-148,600
Closed -$1.55M
QADB
379
DELISTED
QAD Inc. Class B
QADB
-7,572
Closed -$653K
PFPT
380
DELISTED
Proofpoint, Inc.
PFPT
-1,109,046
Closed -$193M
BPY
381
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
-58,275
Closed -$1.1M
QADA
382
DELISTED
QAD Inc.
QADA
-314,684
Closed -$27.4M

Similar funds

ArrowMark Colorado Holdings's Q3 2021 Portfolio in Review

As of Q3 2021, ArrowMark Colorado Holdings held 382 positions worth $12.8B, down 3.8% from $13.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

ArrowMark Colorado Holdings's Q3 2021 filing shows 39 new, 93 increased, 133 reduced and 24 closed positions. Its largest new stake was Invivyd: 2,772,927 shares worth $117M. The largest sale was Proofpoint, Inc., an estimated $193M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Industrials and Technology.

  • ArrowMark Colorado Holdings's largest Q3 2021 buy was Invivyd: 2,772,927 shares worth $117M.
  • ArrowMark Colorado Holdings added most to Purple Innovation in Q3 2021, an estimated $66.2M increase.
  • ArrowMark Colorado Holdings's biggest Q3 2021 reduction was Neurocrine Biosciences, cutting an estimated $54M.
  • ArrowMark Colorado Holdings fully exited Proofpoint, Inc. in Q3 2021, selling an estimated $193M.
  • ArrowMark Colorado Holdings's ten largest holdings make up 23% of its $12.8B portfolio in Q3 2021.
  • ArrowMark Colorado Holdings opened 39 new positions and closed 24 in Q3 2021.
  • ArrowMark Colorado Holdings's portfolio value fell 3.8% quarter-over-quarter to $12.8B.

Based on ArrowMark Colorado Holdings's 13F filing for Q3 2021, filed 15 Nov 2021.